Travere Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

TVTX
Travere Therapeutics

Last Price:

$16.5000

Seasonality Move:

-4.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Travere Therapeutics Stock Forecast

Over the next 52 weeks, Travere Therapeutics has on average historically risen by 2201.5% based on the past 17 years of stock performance.
Travere Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
Is Travere Therapeutics Stock Undervalued?

The current Travere Therapeutics [TVTX] share price is $16.9100. The Score for TVTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
TVTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Travere Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Travere Therapeutics has on average historically risen by 2201.5% based on the past 17 years of stock performance.

Travere Therapeutics Stock Rating

Sell

Travere Therapeutics (TVTX) is a Sell

Is Travere Therapeutics overpriced?

Travere Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%

Travere Therapeutics Stock Price History

Is TVTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

travere.com

52-Week Data

52-Week High:

25.2900

52-Week Low:

7.9310

Prediction Charts

Market Cap:

1.5B

Price in USD:

16.9100

Volume:

1.3M

Beta:

52.9044

Technical Analysis

SMA50:

16.5329

SMA100:

17.5610

SMA200:

17.9510

52-Wk Change:

72.55%

Stock Predictions

Is Travere Therapeutics stock public?

Yes, Travere Therapeutics is a publicly traded company.
What is the Travere Therapeutics stock quote today?

The Travere Therapeutics stock price is 16.9100 USD today.
How to buy Travere Therapeutics stock online?

You can buy Travere Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jun-24	14.7000	15.2400	15.2400	14.3600
Jun-25	15.2800	14.9450	15.3000	14.6100
Jun-26	14.9900	15.1300	15.1500	14.7100
Jun-27	15.2100	14.7800	15.2700	14.5550
Jun-30	14.8000	14.7900	15.1750	14.7200
Jul-1	14.6500	14.7100	15.0800	14.3600
Jul-2	14.7100	14.8400	15.0000	14.4200
Jul-3	14.8600	15.0100	15.0900	14.8400
Jul-7	14.9800	14.6050	15.1600	14.4400
Jul-8	14.6900	15.3000	15.3300	14.6900
Jul-9	15.6500	16.3300	16.3500	15.4500
Jul-10	16.2900	16.5500	16.6350	16.0301
Jul-11	16.3900	16.4700	16.5950	16.2500
Jul-14	16.4200	16.9100	17.3200	16.3800

Travere Therapeutics Earnings

Travere Therapeutics Earnings Report: Per Share Travere Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Travere Therapeutics Forecast Revenue Growth

Travere Therapeutics Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.27 per share, an increase this year of $2.55 per share, and an increase next year of $1.62 per share.

* Travere Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.